NASDAQ · SERVICES-PREPACKAGED SOFTWARE · SMALL CAP
BIO KEY International Inc. BKYI
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$5.9M
▼ 14.3% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-161.2%
Net margin · FY25
-120.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 5.9M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
The company lost 121 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-161.2%
Return on equity, FY2025
ROE
Operating margin-115.0%
Net margin-120.6%
Return on assets-84.6%
Each USD of equity lost 161 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+15.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−5.4%
+15.9%
+1.2%
+3.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 8.3M
total assets, end of FY2025
Total assetsUSD 8.3M
EquityUSD 5.1M
CashUSD 2.7M
Current ratio1.47×
Equity funds 62% of total assets.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
Income tax $B
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
·
0.0
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
EPS, diluted $
·
·
·
·
−0.65
−2.08
−8.21
−0.73
−0.76
−0.89
−0.36
−0.03
−0.06
0.00
−0.02
−0.01
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−161.2
−177.9
−267.8
−113.9
−28.2
−107.2
−356.6
−56.7
−29.3
−24.9
−19.6
−208.1
·
·
·
−53.9
Shares out B
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.07
0.06
0.08
0.08
0.08
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
62 of 62
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed